↑↓ navigate ↵ open esc close
SELL TO STATE.
Start free trial
Spain PLACE contract award · ocds-ted-452669-2025

Spain – Various medicinal products – Suministro del medicamento QARZIBA 20 mg/4,5 ml (Dinutuximab Beta 20 mg/4,5 ml vial

Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria awarded €493K to RECORDATI RARE DISEASES SPAIN SLU for Construction & Public Works in July 2025 — one of 94 awards this buyer has made, above its typical award size.

Construction & Public Works
11 Jul 2025
Award date
€493K
Contract value

Buying agency

Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria
94 Awards
€338K Avg award
Above vs typical

Winning supplier

RECORDATI RARE DISEASES SPAIN SLU
3 Awards
2 Buyers
€493K Total won

Contract description

Spain – Various medicinal products – Suministro del medicamento QARZIBA 20 mg/4,5 ml (Dinutuximab Beta 20 mg/4,5 ml vial)

Premium

Related awards · Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria

94 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Tender no.SupplierAmountDateSector

Full dataset

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →

50 more awards from this buyer · full history & CSV export

Premium

Other wins · RECORDATI RARE DISEASES SPAIN SLU

3 wins

The supplier's complete win history across every buyer it sells to — not just the handful shown here.

Tender no.BuyerAmountDateSector
Locked rows — unlock the full dataset below.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria and RECORDATI RARE DISEASES SPAIN SLU — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up